Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.
about
Decidual soluble factors participate in the control of HIV-1 infection at the maternofetal interfaceHuman immunodeficiency virus type 1 Nef mediates sustained membrane expression of tumor necrosis factor and the related cytokine LIGHT on activated T cells.Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infectionAbsolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytesHIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox statePathogenesis of human immunodeficiency virus infectionSpecific NF-kappa B subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcriptionRegulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factorsHeterocyclic compounds that inhibit Rev-RRE function and human immunodeficiency virus type 1 replication.Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophagesTransdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplicationCytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccinesRecent developments in human immunodeficiency virus-1 latency researchElevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infectionApolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature reviewERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaBCytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteineThe thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitroInhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitorsPhotodynamic inactivation of infectivity of human immunodeficiency virus and other enveloped viruses using hypericin and rose bengal: inhibition of fusion and syncytia formationCystamine potently suppresses in vitro HIV replication in acutely and chronically infected human cellsAnti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-alpha-induced HIV-1 replication in latently infected OM10.1 and Ach2 cellsThalidomide inhibits the replication of human immunodeficiency virus type 1Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replicationInhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type 1 replication and cytokine production in primary T cells: involvement of NF-kappaB and NFATEpigenetic regulation of HIV-1 latency by cytosine methylationCocaine enhances HIV-1 replication in CD4+ T cells by down-regulating MiR-125bAn in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patientsThe anti-inflammatory activity of curcumin protects the genital mucosal epithelial barrier from disruption and blocks replication of HIV-1 and HSV-2The Cellular Thioredoxin-1/Thioredoxin Reductase-1 Driven Oxidoreduction Represents a Chemotherapeutic Target for HIV-1 Entry InhibitionCharacterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loopEvaluation of the effect of pyrimethamine, an anti-malarial drug, on HIV-1 replicationHIV does not replicate in naive CD4 T cells stimulated with CD3/CD28Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapyeEF2 and Ras-GAP SH3 domain-binding protein (G3BP1) modulate stress granule assembly during HIV-1 infectionCD8(+) T-cell effector function and transcriptional regulation during HIV pathogenesisAcetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32.Cytokine influence on simian immunodeficiency virus replication within primary macrophages. TNF-alpha, but not GMCSF, enhances viral replication on a per-cell basisSmall-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activationGlycoproteomic analysis identifies human glycoproteins secreted from HIV latently infected T cells and reveals their presence in HIV+ plasma
P2860
Q21245044-76EE6BC7-8306-4E3C-B94E-A9C7F3C06621Q24527208-727ADD5D-3480-4722-9502-8AE81C7796A8Q24550678-6E500AAD-2A25-41E0-86F4-22FAD92539F3Q24568326-9AFD4551-8E2A-4BBB-9056-C8DF1013EA7AQ24568360-62EF5EF1-2FE3-462F-A9F9-2FC534D7C37EQ24634681-EBEB3E55-3197-4CFC-B6F9-1B55CCEC4480Q24645001-C47DBF01-7107-4E52-B5DA-DC8739582030Q24651506-2003DB73-26B8-49EB-AA42-99481B9217EDQ24652351-F17A506F-5182-462D-BB89-DBA7BDD8934DQ24676612-49321BDC-1082-4C65-811B-295FA5C2C131Q24681560-1F3E88EF-4409-4DA9-9A13-DFF62F71D850Q26827712-965A2242-DA50-4238-8ABA-93BD0009E2D0Q27013114-711E3038-BF00-42DA-8C95-3BDDE34E275AQ27486378-149D5CE5-92F3-4AFF-B4D3-ED2A977D1DB1Q27491003-FD264519-5E0E-4696-BA9D-7A78C302228DQ28144441-C5614465-5446-4A56-9D8A-67A2327FE81AQ28329402-8CEFDDC1-70C5-43D8-A1C0-C6013BF91F5BQ28343837-AEB4A326-6680-40F3-B43D-4465C8F7B842Q28344365-05F34D89-CBCE-45E7-865A-51628728FEBCQ28367994-ADA9F3C4-368F-4E47-BD4C-688E01A99911Q28369684-C3359F3F-9686-4695-A1E1-E95F35142C44Q28370905-7AD982E3-6244-4298-B84E-DE78A5505B49Q28378516-9BE3AD77-491A-485A-ACB3-7314AD6922E0Q28378673-FB46C857-F2AD-4EC5-8596-217EA2E17615Q28379490-E5C67BA5-A248-457D-B088-628AE065CD6EQ28475636-8946BC72-3456-4CFA-85EE-333F52504897Q28484311-79A043BE-4F2E-4B64-B443-770432DBC29FQ28538015-82E9374A-0306-4CB8-9FFF-9000A28BF169Q28546013-CB9878A7-3DE1-47C8-B75C-0EF972FD1ECAQ28552932-9749959F-5031-4D3D-8E73-823152FE46ECQ28645865-9CA65870-6435-4292-8AEA-81C31476EFC8Q28748825-044D8A5B-447F-483E-8EB9-6BF247A3DF16Q28770153-1279DDCC-2DF1-4D00-B380-27AF76C6B88DQ29615993-643C4041-354D-4FD2-873A-6F3D463457ECQ30009320-8E5CBD45-56FB-4E61-B998-C22B7E3FDD74Q30432007-CCAD8205-1998-4B24-98A4-C54FCA2B8F85Q33236503-B18A2924-E83A-4BB4-84F2-A3AC5A71833EQ33417664-24898341-DBBC-4D24-9518-746C2C1AD640Q33508788-6FAD6009-4B3F-4D6C-A356-3FA84DD90F97Q33589518-84962A17-0D89-4740-B0FD-C71682984E8E
P2860
Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.
description
1989 nî lūn-bûn
@nan
1989 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Tumor necrosis factor alpha in ...... nically infected T-cell clone.
@ast
Tumor necrosis factor alpha in ...... nically infected T-cell clone.
@en
type
label
Tumor necrosis factor alpha in ...... nically infected T-cell clone.
@ast
Tumor necrosis factor alpha in ...... nically infected T-cell clone.
@en
prefLabel
Tumor necrosis factor alpha in ...... nically infected T-cell clone.
@ast
Tumor necrosis factor alpha in ...... nically infected T-cell clone.
@en
P2093
P2860
P356
P1476
Tumor necrosis factor alpha in ...... nically infected T-cell clone.
@en
P2093
P2860
P304
P356
10.1073/PNAS.86.7.2365
P407
P577
1989-04-01T00:00:00Z